Search

everythinglearnresearchcommunity

for

Search:↓

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Melatonin improved mental health and metabolism in women with PCOS.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Isotretinoin effectively reduces acne but causes dry skin, higher skin pH, more redness, and hair loss.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

The document concludes that there is no clear definition of adequate health insurance, and a consistent method to measure underinsurance is needed.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

It's unclear which molecules best characterize dry skin due to inconsistent findings.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Skin diseases, especially psoriasis, greatly affect people's quality of life, similar to chronic diseases.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

SVF-enhanced adipose transplantation shows potential as a hair loss treatment.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Tralokinumab for atopic dermatitis may cause side effects like dizziness, headache, nausea, hair loss, and acne.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.